Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma

Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma

Abstract Background Although immunotherapy has shown clinical activity in lung adenocarcinoma (LUAD), LUAD prognosis has been a perplexing problem. We aimed to construct an immune-related lncRNA pairs (IRLPs) score for LUAD and identify what immunosuppressor are appropriate for which group of people...

Full description

Bibliographic Details
Main Authors: Jinman Zhuang, Zhongwu Chen, Zishan Chen, Jin Chen, Maolin Liu, Xinying Xu, Yuhang Liu, Shuyan Yang, Zhijian Hu, Fei He
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Respiratory Research
Subjects:
LUAD
IRLPs signature
Biomarker
Prognosis
Immunosuppressant
Online Access:https://doi.org/10.1186/s12931-022-02043-4

Internet

https://doi.org/10.1186/s12931-022-02043-4

Similar Items